LOS ANGELES–(BUSINESS WIRE) – The law firm Schall, a national law firm for shareholder rights, is filing a class action lawsuit against Verrica Pharmaceuticals Inc. ("Verrica" or "the company") (NASDAQ: VRCA) for violations of Sections 10 (b) and 20 (a ) of the Securities Exchange Act of 1934 and Rule 10b-5 published by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between September 16, 2019 and June 29, 2020 (including the "class period") are asked to contact the company before September 14, 2020.
If you are a shareholder who has suffered a loss, click here to participate.
We also recommend that you contact Brian Schall of the Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the company's website at www.schallfirm.com or by email at firstname.lastname@example.org.
In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you take no action, you can remain an absent class member.
According to the complaint, the company made false and misleading statements about the market. Verrica's proprietary VP-102 applicator posed a safety hazard to patients if the instructions were not followed exactly. Because of this risk, the company has integrated additional user functions into the applicator. The applicator change would in turn require additional tests and supporting data. This additional work is expected to delay VP-102 regulatory approval. Based on these facts, the company's public statements throughout the teaching period were incorrect and essentially misleading. When the market learned the truth about Verrica, investors suffered damage.
Join the case to make up for your losses.
The law firm Schall represents investors all over the world and specializes in class actions and shareholder litigation.
In some countries, this press release may be considered a lawyer’s advertisement in accordance with applicable laws and ethical rules.